There is a newer version of the record available.

Published April 6, 2023 | Version v1

Rational Modification of Human Gut Microbial Metabolites by Dietary Resistant Starch in Patients After Allogeneic Hematopoietic Stem Cell Transplantation: A Prospective Feasibility Study

Description

We conducted a prospective longitudinal feasibility study in patients undergoing allo-HCT for hematological malignancies to test the hypothesis that defined and consistent administration of resistant starch will rationally modify intestinal microbiota dependent metabolites, particularly the short chain fatty acids (SCFA), such as butyrate.  Ten adults undergoing human leukocyte antigen-matched, related-donor myeloablative allo-HCT were enrolled and received resistant potato starch (RPS) daily from day -7 to day 100 after allo-HCT. 

Files

Plasma_metabolites.csv

Files (109.7 kB)

Name Size Download all
md5:11e2e37611743c3f536e49fd87764033
95.5 kB Preview Download
md5:e1edbfc78c97f56c8ad343c1890e6bfa
10.2 kB Preview Download
md5:9879384e3ac939a462902e3eee13768a
3.9 kB Preview Download